DAVIS GREGORY D (Head of Research & Technology) sold 37.7% of their position (69.83K shares) of SANGAMO THERAPEUTICS, INC on the open market
Open‑market sale worth $17.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/23/2026ACC: 0002041855-26-000008
Officer· Head of Research & Technology
Since Feb 2026
-69.83K
Net shares
Net seller
$17.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
69.83K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−69.83K
Price / share
$0.25
Trade value
$17.69K
% of position
37.7%
4/22/2026
185.11K→115.28K
Total
Net shares
−69.83K
Net value
-$17.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/22/2026 | S · Sale | −69.83K | $0.25 | $17.69K | 37.7% | 185.11K | 115.28K |
| Total | −69.83K | -$17.69K | ||||||
Derivative Transactions0
No derivative transactions reported